Point72 (Difc) LTD Rezolute, Inc. Transaction History
Point72 (Difc) LTD
- $2.72 Trillion
- Q4 2024
A detailed history of Point72 (Difc) LTD transactions in Rezolute, Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 3,035 shares of RZLT stock, worth $13,991. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,035Holding current value
$13,991% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RZLT
# of Institutions
70Shares Held
43.8MCall Options Held
187KPut Options Held
24.6K-
Federated Hermes, Inc. Pittsburgh, PA11.3MShares$52 Million0.13% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.86MShares$13.2 Million0.69% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.8MShares$12.9 Million2.6% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.53MShares$11.6 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.32MShares$10.7 Million0.0% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $179M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...